Merck & Co., Inc. Share Price

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse 01:30:02 27/04/2024 am IST 5-day change 1st Jan Change
131.2 USD +0.37% Intraday chart for Merck & Co., Inc. +4.31% +20.34%
Sales 2024 * 64.02B 5,338B Sales 2025 * 68.48B 5,710B Capitalization 332B 27,709B
Net income 2024 * 19.47B 1,623B Net income 2025 * 21.96B 1,831B EV / Sales 2024 * 5.49 x
Net Debt 2024 * 18.89B 1,575B Net Debt 2025 * 7.52B 627B EV / Sales 2025 * 4.96 x
P/E ratio 2024 *
16.9 x
P/E ratio 2025 *
14.7 x
Employees 71,000
Yield 2024 *
2.33%
Yield 2025 *
2.46%
Free-Float 70.75%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.37%
1 week+4.31%
Current month-0.57%
1 month+4.53%
3 months+8.59%
6 months+24.30%
Current year+20.34%
More quotes
1 week
125.35
Extreme 125.35
132.80
1 month
124.50
Extreme 124.5
132.80
Current year
109.16
Extreme 109.16
133.10
1 year
99.14
Extreme 99.14
133.10
3 years
70.89
Extreme 70.89
133.10
5 years
65.25
Extreme 65.25
133.10
10 years
45.69
Extreme 45.69
133.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 01/14/01
Director of Finance/CFO 55 01/90/01
Chief Tech/Sci/R&D Officer 55 01/20/01
Members of the board TitleAgeSince
Director/Board Member 63 27/07/27
Director/Board Member 67 01/15/01
Director/Board Member 69 01/18/01
More insiders
Date Price Change Volume
26/24/26 131.2 +0.37% 7,758,230
25/24/25 130.7 +2.93% 12,750,052
24/24/24 127 +0.09% 7,128,300
23/24/23 126.9 -0.05% 7,743,961
22/24/22 126.9 +0.92% 7,805,992

Delayed Quote Nyse, April 27, 2024 at 01:30 am IST

More quotes
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
131.2 USD
Average target price
140.1 USD
Spread / Average Target
+6.80%
Consensus